← Back to Search

Group Prenatal Care for Depression During Pregnancy (EleVATE GC Trial)

N/A
Waitlist Available
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up delivery
Awards & highlights

EleVATE GC Trial Summary

This trial will study whether the "EleVATE GC" intervention can reduce depression, preterm birth, and low birthweight in African-American women. If it is effective, this model could be used to help improve mental and obstetric health for low-income women of color across the US.

Who is the study for?
This trial is for African-American women who are pregnant, at high risk of postpartum depression, and under 18 weeks' gestation. They must be able to give informed consent, attend group prenatal visits, speak English or Spanish, and have a history that may increase their risk of depression. Women with multiple pregnancies or serious health issues are not eligible.Check my eligibility
What is being tested?
The study tests EleVATE Group Care against Individual Prenatal Care to see if it can reduce perinatal depression and improve birth outcomes in low-income African-American women. Participants will either join the group care model or receive standard individual care.See study design
What are the potential side effects?
Since this trial involves different methods of prenatal care rather than medication, there aren't typical side effects like you'd expect from drugs. However, participants might experience varying levels of comfort or stress based on the type of care they receive.

EleVATE GC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28-40 week visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28-40 week visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Perinatal Depression
Secondary outcome measures
Anxiety
Maternal Attachment (Antenatal)
Maternal Attachment (Postnatal)
+6 more

EleVATE GC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group Prenatal CareExperimental Treatment1 Intervention
Group prenatal care model
Group II: Individual Prenatal CareActive Control1 Intervention
Individual prenatal care

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,483 Total Patients Enrolled
6 Trials studying Postpartum Depression
2,471 Patients Enrolled for Postpartum Depression

Media Library

EleVATE Group Care Clinical Trial Eligibility Overview. Trial Name: NCT04838210 — N/A
Postpartum Depression Research Study Groups: Group Prenatal Care, Individual Prenatal Care
Postpartum Depression Clinical Trial 2023: EleVATE Group Care Highlights & Side Effects. Trial Name: NCT04838210 — N/A
EleVATE Group Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04838210 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients able to participate in this current experiment?

"According to clinicaltrials.gov, this medical trial is not currently accepting new patients; the initial posting was made on May 21st 2021 and the last update occurred November 22nd 2022. However, there are 1,411 other studies that still require volunteers at present."

Answered by AI

Who else is applying?

What state do they live in?
Kansas
How old are they?
18 - 65
What site did they apply to?
University of Missouri-Kansas City/Truman Health Centers-Kansas City
What portion of applicants met pre-screening criteria?
Met criteria
~111 spots leftby Jun 2025